BRIDGET COYNE: Open Payments
NPI 1417032368 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,781 in 78 payments from 14 companies in 2025. Trend: 2023 $1,886 · 2024 $1,081 · 2025 $1,781
Food & beverage: $1,583Education: $198
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 30 | $924 |
| ABBVIE INC. | 27 | $350 |
| Gilead Sciences, Inc. | 3 | $81 |
| Phathom Pharmaceuticals, Inc. | 1 | $74 |
| GENZYME CORPORATION | 2 | $48 |
| QOL Medical, LLC | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
| PFIZER INC. | 2 | $37 |
| Madrigal Pharmaceuticals | 2 | $36 |
Products named: TREMFYA, RINVOQ, VOQUEZNA, SKYRIZI, DUPIXENT, Sucraid, ENTYVIO, XIFAXAN.
Industry payments across CO — which companies pay providers there.
